These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
276 related items for PubMed ID: 24605036
21. Increased immunoendocrine cells in intestinal mucosa of postinfectious irritable bowel syndrome patients 3 years after acute Shigella infection--an observation in a small case control study. Kim HS, Lim JH, Park H, Lee SI. Yonsei Med J; 2010 Jan; 51(1):45-51. PubMed ID: 20046513 [Abstract] [Full Text] [Related]
23. Dietary guidance normalizes large intestinal endocrine cell densities in patients with irritable bowel syndrome. Mazzawi T, Hausken T, Gundersen D, El-Salhy M. Eur J Clin Nutr; 2016 Feb; 70(2):175-81. PubMed ID: 26603880 [Abstract] [Full Text] [Related]
24. Subclinical mucosal inflammation in diarrhea-predominant irritable bowel syndrome (IBS) in a tropical setting. De Silva AP, Nandasiri SD, Hewavisenthi J, Manamperi A, Ariyasinghe MP, Dassanayake AS, Jewell DP, de Silva HJ. Scand J Gastroenterol; 2012 Jun; 47(6):619-24. PubMed ID: 22486731 [Abstract] [Full Text] [Related]
25. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation. Singh P, Staller K, Barshop K, Dai E, Newman J, Yoon S, Castel S, Kuo B. World J Gastroenterol; 2015 Jul 14; 21(26):8103-9. PubMed ID: 26185382 [Abstract] [Full Text] [Related]
26. Human rectal endocrine cells and aging. Sandström O, el-Salhy M. Mech Ageing Dev; 1999 May 17; 108(3):219-26. PubMed ID: 10405982 [Abstract] [Full Text] [Related]
27. Possible role of peptide YY (PYY) in the pathophysiology of irritable bowel syndrome (IBS). El-Salhy M, Hatlebakk JG, Hausken T. Neuropeptides; 2020 Feb 17; 79():101973. PubMed ID: 31727345 [Abstract] [Full Text] [Related]
28. Differential mRNA expression in ileal and colonic biopsies in irritable bowel syndrome with diarrhea or constipation. Camilleri M, Magnus Y, Carlson P, Wang XJ, Chedid V, Maselli D, Taylor A, McKinzie S, Kengunte Nagaraj N, Busciglio I, Nair A. Am J Physiol Gastrointest Liver Physiol; 2022 Aug 01; 323(2):G88-G101. PubMed ID: 35502856 [Abstract] [Full Text] [Related]
29. Changes in small intestinal chromogranin A-immunoreactive cell densities in patients with irritable bowel syndrome after receiving dietary guidance. Mazzawi T, El-Salhy M. Int J Mol Med; 2016 May 01; 37(5):1247-53. PubMed ID: 26987104 [Abstract] [Full Text] [Related]
30. Increased intestinal mucosal leptin levels in patients with diarrhea-predominant irritable bowel syndrome. Liu DR, Xu XJ, Yao SK. World J Gastroenterol; 2018 Jan 07; 24(1):46-57. PubMed ID: 29358881 [Abstract] [Full Text] [Related]
31. Increased expression of brain-derived neurotrophic factor is correlated with visceral hypersensitivity in patients with diarrhea-predominant irritable bowel syndrome. Zhang Y, Qin G, Liu DR, Wang Y, Yao SK. World J Gastroenterol; 2019 Jan 14; 25(2):269-281. PubMed ID: 30670915 [Abstract] [Full Text] [Related]
32. Serotonin and serotonin transporter in the rectum of patients with irritable bowel disease. El-Salhy M, Wendelbo I, Gundersen D. Mol Med Rep; 2013 Aug 14; 8(2):451-5. PubMed ID: 23778763 [Abstract] [Full Text] [Related]
33. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome. Park JH, Rhee PL, Kim HS, Lee JH, Kim YH, Kim JJ, Rhee JC. J Gastroenterol Hepatol; 2006 Jan 14; 21(1 Pt 1):71-8. PubMed ID: 16706815 [Abstract] [Full Text] [Related]
34. Assessment of Anti-vinculin and Anti-cytolethal Distending Toxin B Antibodies in Subtypes of Irritable Bowel Syndrome. Rezaie A, Park SC, Morales W, Marsh E, Lembo A, Kim JH, Weitsman S, Chua KS, Barlow GM, Pimentel M. Dig Dis Sci; 2017 Jun 14; 62(6):1480-1485. PubMed ID: 28451914 [Abstract] [Full Text] [Related]
35. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. Buhner S, Li Q, Vignali S, Barbara G, De Giorgio R, Stanghellini V, Cremon C, Zeller F, Langer R, Daniel H, Michel K, Schemann M. Gastroenterology; 2009 Oct 14; 137(4):1425-34. PubMed ID: 19596012 [Abstract] [Full Text] [Related]
36. Gender distribution in irritable bowel syndrome is proportional to the severity of constipation relative to diarrhea. Herman J, Pokkunuri V, Braham L, Pimentel M. Gend Med; 2010 Jun 14; 7(3):240-6. PubMed ID: 20638629 [Abstract] [Full Text] [Related]
37. Changes in duodenal enteroendocrine cells in patients with irritable bowel syndrome following dietary guidance. Mazzawi T, El-Salhy M. Exp Biol Med (Maywood); 2017 Jul 14; 242(13):1355-1362. PubMed ID: 28737477 [Abstract] [Full Text] [Related]
38. Irritable bowel syndrome subtypes differ in body awareness, psychological symptoms and biochemical stress markers. Eriksson EM, Andrén KI, Eriksson HT, Kurlberg GK. World J Gastroenterol; 2008 Aug 21; 14(31):4889-96. PubMed ID: 18756596 [Abstract] [Full Text] [Related]
39. Latent structure of irritable bowel syndrome symptom severity. Jasper F, Egloff B, Roalfe A, Witthöft M. World J Gastroenterol; 2015 Jan 07; 21(1):292-300. PubMed ID: 25574104 [Abstract] [Full Text] [Related]
40. Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin. Shekhar C, Monaghan PJ, Morris J, Issa B, Whorwell PJ, Keevil B, Houghton LA. Gastroenterology; 2013 Oct 07; 145(4):749-57; quiz e13-4. PubMed ID: 23872499 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]